spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  blood purification 

 HSMN NewsFeed - 2 Nov 2022
'Enhanced Lung Rest' with CytoSorb and ECMO Achieves High Survival in 100 Critically Ill COVID-19 Patients with Refractory Lung Failure from Five Major U.S. Hospitals
Devices
 HSMN NewsFeed - 1 Jun 2022
CytoSorbents Partners with Nikkiso to Distribute the PureADJUST Hemoperfusion Blood Pump and Supplies in 14 Countries
Devices Distribution
 HSMN NewsFeed - 2 May 2022
CytoSorbents Awarded Preferred Supplier Agreement with Asklepios, One of the Largest Private Hospital Operators in Germany
Devices Group Purchasing
 HSMN NewsFeed - 20 Dec 2021
CytoSorbents Announces Publication of U.S. CTC Multicenter Registry Results Using CytoSorb(R) in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO)
Devices
 HSMN NewsFeed - 10 Sep 2021
CytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for the U.S. Clinical Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR(TM) Antithrombotic Removal System During Urgent Cardiothoracic Surgery
Devices Surgery FDA
 HSMN NewsFeed - 12 Aug 2021
Second U.S. FDA Breakthrough Device Designation Granted to CytoSorbents' DrugSorb-ATR(TM) Antithrombotic Removal System Adding the Removal of Market-Leading Direct Oral Anticoagulants During Urgent Cardiothoracic Surgery
Devices FDA
 HSMN NewsFeed - 11 Jan 2021
CytoSorbents Appoints James Komsa as Vice President - U.S. Sales and Marketing
Devices Personnel
 HSMN NewsFeed - 31 Jul 2020
CytoSorbents Awarded $4.4 Million Contract by the U.S. Department of Defense to Complete HemoDefend-BGA Adsorber Preclinical Development
Devices
 HSMN NewsFeed - 28 Jul 2020
CytoSorbents Announces the REFRESH 2-AKI Trial Data Monitoring Committee Has Recommended Study Resumption Following Favorable Review of Safety Data
Devices
 HSMN NewsFeed - 24 Jun 2020
CytoSorbents Announces Commercial Launch and Immediate Availability of CytoSorb To Treat Cytokine Storm In Many Latin American Countries As COVID-19 Cases Rise
Devices Product Launch
 HSMN NewsFeed - 12 May 2020
CytoSorb(R) is E.U. Approved to Remove Rivaroxaban, a Leading Factor Xa Inhibitor and Novel Oral Anticoagulant, During On-Pump Cardiothoracic Surgery
Devices Regulatory
 HSMN NewsFeed - 4 May 2020
CytoSorbents Promotes Vincent J. Capponi to President
Devices Personnel
 HSMN NewsFeed - 27 Apr 2020
Cytosorbents Appoints Dr. Efthymios N. Deliargyris, M.D., As Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 13 Apr 2020
U.S. FDA Grants CytoSorb(R) Emergency Use Authorization for Use in Patients with COVID-19 Infection
Devices FDA
 HSMN NewsFeed - 31 Mar 2020
CytoSorb(R) Receives Marketing Approval in Mexico with Commercialization to Commence with Partner Fresenius Medical Care
Devices Regulatory
 HSMN NewsFeed - 29 Jan 2020
CytoSorb(R) is Approved and Available for the Removal of Ticagrelor, a Leading Anti-Platelet Drug, During Cardiopulmonary Bypass in the E.U.
Devices Regulatory Product Launch
 HSMN NewsFeed - 1 Nov 2019
CytoSorbents Enrolls First Patient in TISORB Trial and Opens Operating Subsidiary in the United Kingdom
Devices
 HSMN NewsFeed - 8 Apr 2019
ACell Enters Exclusive Chinese Product Supply and Distribution Agreement for Cytal and MicroMatrix Wound Management Products
Devices Wound Care Distribution
 HSMN NewsFeed - 25 Mar 2019
Israel Approves CytoSorb Registration, CytoSorbents Announces Gad Medical as Distributor
Devices Regulatory Distribution
 HSMN NewsFeed - 7 Dec 2016
CytoSorb(R) Attains Permanent, Dedicated Reimbursement Code in Core Market of Germany
Devices Reimbursement
 HSMN NewsFeed - 22 Nov 2016
First Successful Treatment of Dengue Fever and Dengue Shock Syndrome Using CytoSorb(R)
Devices
 HSMN NewsFeed - 18 May 2016
CytoSorb(R) Achieves Final Product Registration in Russia
Devices Distribution
 HSMN NewsFeed - 6 Jan 2014
Nikkiso Completes Acquisition of Baxter’s Continuous Renal Replacement Therapy Business
Devices Mergers & Acquisitions
 HSMN NewsFeed - 31 Dec 2013
CytoSorbents Provides Clinical Update on CytoSorb Dosing Study
Devices
 HSMN NewsFeed - 8 Apr 2013
CytoSorbents Announces Trauma Advisory Board
Devices Personnel
 HSMN NewsFeed - 20 Jun 2012
CytoSorbents Appoints Dr. Christian Steiner as VP of Sales and Marketing and Hires Core Sales Force That Marks the Official Launch of CytoSorb(R) in Germany
Devices Personnel
 HSMN NewsFeed - 8 Feb 2011
Pervasis Receives FDA Fast Track Status for Vascugel(R) to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
Biopharmaceuticals Interventional FDA
 HSMN NewsFeed - 19 Oct 2010
Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
Devices Personnel
 HSMN NewsFeed - 7 Oct 2008
Arbios Sells HepatAssist Bioartificial Liver System to HepaLife Technologies, Inc.
Devices Acquisitions
 HSMN NewsFeed - 5 Aug 2008
Arbios Announces It Has Suspended Operations
Devices
 HSMN NewsFeed - 12 May 2008
Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device
Devices FDA
 HSMN NewsFeed - 17 Dec 2007
Medtronic and Weigao Announce Joint Venture in China
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 16 Oct 2007
MedaSorb Completes Key Step to Begin Clinical Study in Europe for CytoSorb(TM) in the Treatment of Sepsis
Devices
 HSMN NewsFeed - 25 Sep 2007
Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
Devices FDA
 HSMN NewsFeed - 19 Sep 2007
Arbios Announces Management Changes
Devices Personnel
 HSMN NewsFeed - 7 Sep 2007
Arbios Systems Publishes Positive Results From Completed Sepet(TM) Feasibility Clinical Trial
Devices
 HSMN NewsFeed - 30 Jul 2007
MedaSorb to Pursue 6 Billion Dollar Sepsis Market in Europe
Devices Regulatory
 HSMN NewsFeed - 23 Apr 2007
Arbios Raises $4.8 Million To Advance Its SEPET(TM) Liver Assist Device Into Pivotal Clinical Trials
Devices Venture Capital
 HSMN NewsFeed - 30 Mar 2007
Arbios Systems Strengthens Its Proprietary Position for Blood Filtration Therapies in Critical Care Medicine
Devices Licensing
 HSMN NewsFeed - 27 Oct 2006
Arbios Systems Announces Presentation of SEPET(TM) Clinical Data at the 57th Annual AASLD Meeting
Devices
 HSMN NewsFeed - 6 Jul 2006
Arbios Adds University of California at San Francisco (UCSF) As Fourth Participating Site in the SEPET(TM) Clinical Feasibility Trial
Devices
 HSMN NewsFeed - 23 Jun 2006
Arbios Founder and Chief Scientific Officer, Jacek Rozga, Invited to Present the SEPET(TM) Liver Assist Device at the Annual Conference of the European Society of Artificial Organs
Devices
 HSMN NewsFeed - 15 May 2006
Arbios Systems Presents Positive Interim Safety and Patient Outcome Results From the SEPET(TM) Liver Assist Device Clinical Trial
Devices
 HSMN NewsFeed - 22 Mar 2006
Arbios Receives FDA Allowance to Increase Patient Enrollment for SEPET(TM) Clinical Trial and Adds Major Liver Center as a Third Participating Site
Devices FDA
 HSMN NewsFeed - 16 Mar 2006
Arbios Expands Indications for SEPET(TM) Feasibility Trial
Devices FDA
Return to NewsFeed  

 Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 9 additional stories matching:
blood purification
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.